Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:MSON

Misonix (MSON) Stock Price, News & Analysis

Misonix logo

About Misonix Stock (NASDAQ:MSON)

Key Stats

Today's Range
$26.54
$26.54
50-Day Range
$24.89
$26.54
52-Week Range
$11.04
$26.99
Volume
2 shs
Average Volume
60,302 shs
Market Capitalization
$462.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. It operates through the following segments: Surgical and Wound. The Surgical segment consists of BoneScalpel and SonaStar products. The Wound segment consists of SonicOne, TheraSkin and Therion products. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. Misonix was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.

Receive MSON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Misonix and its competitors with MarketBeat's FREE daily newsletter.

MSON Stock News Headlines

We recommended Nvidia in 2016, now we’re recommending this…
The AI boom is just getting started. And the real wealth has still to be made…
Jess Thomson
See More Headlines

MSON Stock Analysis - Frequently Asked Questions

Misonix, Inc. (NASDAQ:MSON) released its quarterly earnings results on Thursday, September, 2nd. The medical equipment provider reported ($0.26) EPS for the quarter, missing analysts' consensus estimates of ($0.24) by $0.02. The medical equipment provider had revenue of $19.69 million for the quarter. Misonix had a negative trailing twelve-month return on equity of 10.36% and a negative net margin of 19.55%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Misonix investors own include Edap Tms (EDAP), Canopy Growth (CGC), Varian Medical Systems (VAR), Fulgent Genetics (FLGT), Ampio Pharmaceuticals (AMPE), Sociedad Química y Minera de Chile (SQM) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
9/02/2021
Today
11/02/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Industry
Laboratory Apparatus & Furniture
Sub-Industry
N/A
Current Symbol
NASDAQ:MSON
Employees
254
Year Founded
1959

Profitability

Net Income
$-14,470,000.00
Pretax Margin
-19.37%

Debt

Sales & Book Value

Annual Sales
$74.02 million
Book Value
$7.77 per share

Miscellaneous

Free Float
11,893,000
Market Cap
$462.06 million
Optionable
Not Optionable
Beta
1.36

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (NASDAQ:MSON) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners